Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia

被引:11
作者
Basile, Umberto [1 ]
Marino, Mariapaola [2 ]
Gragnani, Laura [3 ,4 ]
Napodano, Cecilia [5 ]
Gulli, Francesca [6 ]
Pocino, Krizia [5 ]
Lorini, Serena [3 ,4 ]
Santini, Stefano Angelo [1 ]
Basile, Valerio [7 ]
Miele, Luca [5 ]
Zignego, Anna Linda [3 ,4 ]
Rapaccini, Gian Ludovico [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Ist Patol Gen, Rome, Italy
[3] AOUC, Interdept Ctr Syst Manifestn Hepatitis Viruses MA, Dept Expt & Clin Med, Florence, Italy
[4] AOUC, Dept Oncol, Florence, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Med Interna & Gastroenterol, Rome, Italy
[6] Osped Madre Giuseppina Vannini, Dipartimento Med Lab, Rome, Italy
[7] Univ Tor Vergata, Dipartimento Med Lab, Rome, Italy
关键词
Hepatitis C virus; Mixed cryoglobulinemia; Free light chains; Vascular endothelial growth factor; Biomarkers; FREE LIGHT-CHAINS; ENDOTHELIAL GROWTH-FACTOR; VEGF; LYMPHOMA;
D O I
10.1016/j.jim.2019.112687
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Infections, autoimmunity and cancer play a role as determinants of etiology in Hepatitis C virus (HCV) related mixed cryoglobulinemia (MC). Several factors of risk have been suggested as markers of pathogenesis and progression of HCV-related MC into B cell Non-Hodgkin's Lymphoma (B-NHL). Here, we evaluated IgG subclass distribution, free light chains (FLCs) and vascular endothelial growth factor (VEGF) as a new combination of biomarkers. Methods: We measured IgG1-4 subclasses, FLCs and VEGF levels in sera 53 from HCV-related MC, in comparison with 40 sera from HCV negative patients with rheumatoid arthritis (RA) and 30 from healthy blood donors (HBD). Results: IgG3 levels were significantly higher in HCV-MC patients with a decrement of IgG2 and IgG4; FLC levels significantly increased in both MC and RA patients' groups; serological VEGF was higher in HCV-MC patients than in HBD in correlation with k and lambda levels. Conclusion: Our results suggest that a specific IgG subclasses pattern together with raised levels of FLCs and VEGF could represent the biomarker "signature" of an inflammation multistage of acquired immune system.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
    Ferri, C
    Sebastiani, M
    Giuggioli, D
    Cazzato, M
    Longombardo, G
    Antonelli, A
    Puccini, R
    Michelassi, C
    Zignego, AL
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (06) : 355 - 374
  • [22] RELIABILITY OF IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES (ELISA AND RIBA-II) IN PATIENTS WITH ESSENTIAL MIXED CRYOGLOBULINEMIA (EMC)
    MONTEVERDE, A
    AIROLDI, G
    BALLARE, M
    FORTINA, G
    QUAGLIA, V
    PIGATTO, A
    MANZINI, P
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 (06) : 609 - 613
  • [23] Lymphoproliferation in type II mixed cryoglobulinemia
    Monteverde, A
    Ballare, M
    Bertoncelli, MC
    Zigrossi, P
    Sabattini, E
    Poggi, S
    Pileri, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 : S141 - S147
  • [24] INNER-EAR INVOLVEMENT IN MIXED CRYOGLOBULINEMIA PATIENTS
    BERRETTINI, S
    FERRI, C
    LACIVITA, L
    SEGNINI, G
    LOMBARDINI, F
    BRUSCHINI, P
    LONGOMBARDO, G
    SELLARIFRANCESCHINI, S
    BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 (04): : 370 - 374
  • [25] Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study
    Piluso, A.
    Giannini, C.
    Fognani, E.
    Gragnani, L.
    Caini, P.
    Monti, M.
    Petrarca, A.
    Ranieri, J.
    Urraro, T.
    Triboli, E.
    Laffi, G.
    Zignego, A. L.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e107 - e114
  • [26] Influence of HCV and HIV on Development of Cryoglobulinemia
    Rogalska-Plonska, Magdalena
    Lapinski, Tadeusz Wojciech
    Grzeszczuk, Anna
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    VIRAL IMMUNOLOGY, 2015, 28 (03) : 145 - 152
  • [27] Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study
    Mazzaro, C.
    Monti, G.
    Saccardo, F.
    Zignego, A. L.
    Ferri, C.
    De Vita, S.
    Gabrielli, A.
    Lenzi, M.
    Donada, C.
    Galli, M.
    Pietrogrande, M.
    Pozzato, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (06) : 933 - 941
  • [28] I Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment
    Basile, Umberto
    Gragnani, Laura
    Piluso, Alessia
    Gulli, Francesca
    Urraro, Teresa
    Dell'Abate, Maria T.
    Torti, Eleonora
    Stasi, Cristina
    Monti, Monica
    Rapaccini, Gian Ludovico
    Zignego, Anna Linda
    LIVER INTERNATIONAL, 2015, 35 (09) : 2100 - 2107
  • [29] Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients
    Freitas-de Aguiar, Mariana
    Faria-Janes, Anna L.
    Garcia-Brandes, Gabriela, I
    Takemi-Emori, Christini
    Gomes-Ferraz, Maria L.
    Coelho-Andrade, Luis E.
    Silva-de Souza, Alexandre W.
    ANNALS OF HEPATOLOGY, 2019, 18 (05) : 685 - 692
  • [30] Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia
    Sabino Russi
    Domenico Sansonno
    Maria Addolorata Mariggiò
    Angela Vinella
    Fabio Pavone
    Gianfranco Lauletta
    Silvia Sansonno
    Franco Dammacco
    Arthritis Research & Therapy, 16